Overview
Status
Active
Registry date
2019-04-04
Share capital
5 000,00 PLN
Registered address
ul. Trzebińska 6, 60-003 Poznań, Poland
Electronic delivery address
AE:PL-33217-16884-TTIVT-28
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 451.24kMedianUSD 38.31kAverageUSD 2.31m
Net profit
This companyUSD -333.05kMedianUSD -1.58kAverageUSD -89.61k
Operating costs
This companyUSD 766.88kMedianUSD 56.25kAverageUSD 2.28m
Assets
This companyUSD 251.03kMedianUSD 120.24kAverageUSD 2.72m
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-04-12. Active
09 1090 1362 0000 0001 4230 2124
51 1090 1362 0000 0001 4230 2144
87 1090 1362 0000 0001 4725 8681
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
10 public aid cases recorded, with a total value of $3,742,937.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 27, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $24,311$24,311 | Marszałek Województwa Wielkopolskiego | |
| Dec 31, 2024 | Aid for research and development projects: experimental development | $1.3M$1,329,979 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Dec 31, 2024 | Aid for research and development projects: industrial research | $526.8K$526,789 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-01-01 | Opracowanie technologii opartej o sparalelizowane systemy mikroprzepływowe do kaskadowej filtracji komórek zwierzęcych w ciągłej hodowli perfuzyjnej w skali przemysłowej. | $2.0M$2,047,852 | Fundusze Europejskie dla Nowoczesnej Gospodarki | |
| 2021-04-01 | Opracowanie nowoczesnej technologii zbioru biomasy, opartej na spararelizowanych systemach mikroprzepływowych | $1.6M$1,610,284 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Authorized Representatives
Paweł Kalojan Rusinow – Vice President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ufraction8 Limited | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Biodecsp. z o.o. | $115,508.63 | biodec.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-10-03 | Address change (Ul. Uniwersytetu Poznańskiego 10/B-029, 61-614, Poznań → Ul. Trzebińska 6, 60-003, Poznań) | |
| 2022-01-31 | Address change (Ul. Szelągowska 49, 61-626, Poznań → Ul. Uniwersytetu Poznańskiego 10/B-029, 61-614, Poznań) | |
| 2019-04-04 | Entered in the register |
FAQ
The main business activity of Ufraction8 Pl focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on April 4, 2019.
The headquarters is located at: ul. Trzebińska 6, 60-003 Poznań.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $124,368 in 2024, which is a decrease of 77.5% compared to 2023.
No, the company recorded a net loss of $94,383 in 2024. For comparison, in 2023 the loss was $324,460, meaning the company reduced its loss by 72.4%.
The largest operating cost category falls under employee remuneration. This category amounted to $115,434 in 2024, representing 53% of all operating expenses.
Last updated: 2026-10-04